Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: The complexity of acute and chronic inflammatory processes may either lead to benign prostate hyperplasia (BPH) and/or prostate cancer. Obviously, various tissue cells are activated by chemokines via different chemotaxin receptors which then trigger subsequent processes in angiogenesis, cellular growth, and extravasation as well as neoplasia. METHODS: Using the surgically obtained tissue of patients (n = 36) with BPH or prostate carcinoma (PCA), we studied among others the expression of chemokines (Rantes, IL‐8), chemotaxin receptors (CXCR‐3 and ‐4, CCR‐3, CCR‐5), of matrixmetalloproteinases (MMP‐2 and 9), of Toll‐like (TL) receptors 1, 2, 3, 4, 5, 7, and 9 and of the inducible cyclooxygenase‐2 (cox‐2) by RT‐PCR. Further support for the different properties of tissue from PCA was obtained using two different PCA cell lines (PC3 = androgen resistant cell) or LNCAP cells (androgen sensitive) with emphasis on IL‐8, Il‐6, and PGE 2 release. Cell lines were stimulated with either the tumor necrosis factor‐α (TNF‐α) and lipopolysacharide (LPS) over time. In addition to cytokine release, the quantification of mRNA by lightcycler for cox‐2, IL‐6, and IL‐8 was performed on these cell lines. RESULTS: Remarkable differences in expression were obtained by RT‐PCR when BPH tissue versus PCA was analyzed. Expression of CXCR‐1 after incubation with LPS and TNF‐α showed time‐dependent differences for androgen‐sensitive LNCAP as compared to androgen‐resistant PC‐3 cells. TNF‐α incubation leads to a time‐dependent induction of cox‐2 expression unlike to activation with LPS. Differences with regard to cox‐2, IL‐6, and IL‐8 expression were seen by quantitative lightcycler analysis. Significant differences were also observed when TL receptors 4, 5, 7, and 9 were analyzed which were significantly expressed in BPH‐ as compared to PCA‐tissue. CONCLUSIONS: Our data clearly demonstrate that various inflammatory and cell biological cascades are involved which either lead to BPH or can be linked to the development of PCA. The exact cell biological mechanisms may provide novel therapeutic options in the treatment of both diseases. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of chemokine production at the blood-retina barrier
Crane, I. J., Wallace, C. A., Mckillop‐Smith, S., & Forrester, J. V. (2000) · Immunology · doi:10.1046/j.0019-2805.2000.01105.x · Cited by 77 · cited 1×
“For IL-8 [24]: 50-CCC TCT GCA CCC AGT TTT CCT-30 and 50-ACT CCA AAC CTT TCC ACC CCA-30.”
Cited by
Is Benign Prostatic Hyperplasia (BPH) an Immune Inflammatory Disease?
Kramer, G., Mitteregger, D., & Marberger, M. (2007) · European Urology · doi:10.1016/j.eururo.2006.12.011 · Cited by 464
De Nunzio, C., Kramer, G., Marberger, M., Montironi, R., Nelson, W., Schröder, F., Sciarra, A., & Tubaro, A. (2011) · European Urology · doi:10.1016/j.eururo.2011.03.055 · Cited by 454
Metadata
- Authors
- König, J. E., Senge, T., Allhoff, E. P., & König, W.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2003-11-17
- Volume
- 58
- Issue
- 2
- Pages
- 121-129
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2142480001
- Cited by
- 163
- References
- 1
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. https://app.cochat.ai/papers/10.1002/pros.10317
- The paper
- König, J. E., Senge, T., Allhoff, E. P., & König, W. (2004). Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. The Prostate. https://doi.org/10.1002/pros.10317
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.